Realty Income Corp vs Summit Therapeutics Inc — how do they compare? Realty Income Corp trades at $65.03 (market cap $60.60B), while Summit Therapeutics Inc trades at $14.78 (market cap $11.34B). The key difference: Realty Income Corp is far larger — about 5.3× Summit Therapeutics Inc's market cap, and Realty Income Corp pays a 5% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| O | SMMT | |
|---|---|---|
Market Cap | $60.60B | $11.34B |
Sector | Real Estate | Health |
52-Week High | $67.56 | $29.32 |
52-Week Low | $55.93 | $13.05 |
Enterprise Value | $90.40B | $10.76B |
Dividend Yield | 5% | — |
Trailing returns across standard periods
Latest headlines on both assets
Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →